Rogers, K A
Ruppert, A S
Bingman, A
Andritsos, L A
Awan, F T
Blum, K A
Flynn, J M
Jaglowski, S M
Lozanski, G
Maddocks, K J
Byrd, J C
Woyach, J A
Jones, J A
Article History
Received: 23 July 2015
Revised: 3 September 2015
Accepted: 25 September 2015
First Online: 7 October 2015
Competing interests
: JAJ has served as a consultant for Pharmacyclics and Janssen. KJM has received research support from Pharmacyclics. KAB has received research funding from Pharmacyclics and Janssen. SMJ has received research funding and has served as a consultant for Pharmacyclics. The remaining authors declare no conflict of interest.